GeneDx jumps on fourth quarter revenue beat, strong forecast

GeneDx Holdings

18/02/2025 12:00

** Medical device maker GeneDx's shares  WGS.O  surge 19.3%
to $91.1 premarket 
    ** Co posts Q4 revenue of $95.3 mln, beating analyst est of
$82.23 mln as per data compiled by LSEG 
    ** Co forecasts 2025 revenue in the range of $350 mln to
$360 mln, higher than analysts' expectations of $338.8 mln 
    ** WGS makes medical devices used to diagnose rare genetic
disorders, epilepsy and autism 
     ** Co reports adj Q4 net income of $16.8 mln vs analyst est
of $2.9 mln 
    **  Stock had risen 17.3x in the last 12 months 
    

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))